Septerna Inc
SEPN20.050USD
-0.550-2.67%
收盘 11/03, 16:00（美东）报价延迟15分钟
893.59M总市值
亏损市盈率 TTM
关于 Septerna Inc 公司
Septerna, Inc. 是一家临床阶段的生物技术公司。该公司正在开发由其专有的 Native Complex Platform 支持的 G 蛋白偶联受体 (GPCR) 口服小分子药物发现。其候选产品管线专注于治疗三个治疗领域的患者：内分泌学、免疫学和炎症以及代谢疾病。其工业规模的 Native Complex Platform 旨在首次针对某些 GPCR，发现经过验证的受体的新型结合位点，并寻求广泛的药理学，包括激动剂、拮抗剂和变构调节剂，以实现预期的治疗效果。该公司正在推进一系列口服小分子 GPCR 靶向项目，采用新颖的机制方法治疗多个治疗领域的疾病，以满足未满足需求的患者的需求。该公司专注于主要治疗领域，例如神经病学、女性健康、心血管和呼吸系统疾病。
Septerna Inc简介
公司代码SEPN
公司名称Septerna Inc
上市日期Oct 25, 2024
CEODr. Jeffrey (Jeff) Finer, M.D., Ph.D.
员工数量75
证券类型Ordinary Share
年结日Oct 25
公司地址250 East Grand Avenue, Suite 65
城市SOUTH SAN FRANCISCO
上市交易所NASDAQ Global Market Consolidated
国家United States of America
邮编94080
电话16503383533
网址https://septerna.com/
公司代码SEPN
上市日期Oct 25, 2024
CEODr. Jeffrey (Jeff) Finer, M.D., Ph.D.
Septerna Inc公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Jeffrey (Jeff) Finer, M.D., Ph.D.
Dr. Jeffrey (Jeff) Finer, M.D., Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
826.91K
-12.75%
Dr. Uwe Klein, Ph.D.
Dr. Uwe Klein, Ph.D.
Senior Vice President - Biological Sciences
Senior Vice President - Biological Sciences
135.66K
+20.42%
Dr. Alan Ezekowitz, M.D., Ph.D.
Dr. Alan Ezekowitz, M.D., Ph.D.
Director
Director
117.42K
-22.44%
Mr. Daniel (Dan) Long
Mr. Daniel (Dan) Long
Senior Vice President - Drug Discovery
Senior Vice President - Drug Discovery
101.04K
--
Ms. Samira Shaikhly
Ms. Samira Shaikhly
Chief People Officer
Chief People Officer
36.81K
--
Dr. Jake Simson, Ph.D.
Dr. Jake Simson, Ph.D.
Independent Director
Independent Director
--
--
Mr. Abraham (Abe) Bassan
Mr. Abraham (Abe) Bassan
Independent Director
Independent Director
--
--
Ms. Shalini Sharp
Ms. Shalini Sharp
Independent Director
Independent Director
--
-100.00%
Dr. Bernard J. Coulie, M.D., Ph.D.
Dr. Bernard J. Coulie, M.D., Ph.D.
Independent Director
Independent Director
--
-100.00%
Ms. Elizabeth P. (Liz) Bhatt
Ms. Elizabeth P. (Liz) Bhatt
President
President
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Jeffrey (Jeff) Finer, M.D., Ph.D.
Dr. Jeffrey (Jeff) Finer, M.D., Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
826.91K
-12.75%
Dr. Uwe Klein, Ph.D.
Dr. Uwe Klein, Ph.D.
Senior Vice President - Biological Sciences
Senior Vice President - Biological Sciences
135.66K
+20.42%
Dr. Alan Ezekowitz, M.D., Ph.D.
Dr. Alan Ezekowitz, M.D., Ph.D.
Director
Director
117.42K
-22.44%
Mr. Daniel (Dan) Long
Mr. Daniel (Dan) Long
Senior Vice President - Drug Discovery
Senior Vice President - Drug Discovery
101.04K
--
Ms. Samira Shaikhly
Ms. Samira Shaikhly
Chief People Officer
Chief People Officer
36.81K
--
Dr. Jake Simson, Ph.D.
Dr. Jake Simson, Ph.D.
Independent Director
Independent Director
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 8月20日 周三
更新时间: 8月20日 周三
持股股东
股东类型
持股股东
持股股东
占比
Third Rock Ventures, LLC
23.39%
RA Capital Management, LP
15.69%
Driehaus Capital Management, LLC
10.50%
BVF Partners L.P.
9.86%
Samsara BioCapital, LLC
7.06%
其他
33.50%
持股股东
持股股东
占比
Third Rock Ventures, LLC
23.39%
RA Capital Management, LP
15.69%
Driehaus Capital Management, LLC
10.50%
BVF Partners L.P.
9.86%
Samsara BioCapital, LLC
7.06%
其他
33.50%
股东类型
持股股东
占比
Venture Capital
48.31%
Investment Advisor/Hedge Fund
16.80%
Hedge Fund
16.05%
Investment Advisor
14.45%
Research Firm
3.64%
Individual Investor
2.94%
Private Equity
1.21%
Bank and Trust
0.06%
Insurance Company
0.02%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
157
44.83M
100.55%
-6.53M
2025Q2
140
48.42M
108.66%
+736.53K
2025Q1
139
54.98M
123.75%
+8.24M
2024Q4
107
54.00M
121.73%
+28.70M
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Third Rock Ventures, LLC
10.43M
23.39%
--
--
Jun 30, 2025
RA Capital Management, LP
7.00M
15.69%
--
--
Jun 30, 2025
Driehaus Capital Management, LLC
4.68M
10.5%
+20.52K
+0.44%
Jun 30, 2025
BVF Partners L.P.
4.40M
9.86%
--
--
Jun 30, 2025
Samsara BioCapital, LLC
3.15M
7.06%
--
--
Jun 30, 2025
Invus Public Equities Advisors, LLC
2.20M
4.94%
--
--
Jun 30, 2025
Goldman Sachs & Company, Inc.
1.42M
3.18%
-33.09K
-2.28%
Jun 30, 2025
The Vanguard Group, Inc.
1.41M
3.17%
+419.32K
+42.14%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
1.25M
2.81%
+90.92K
+7.82%
Jun 30, 2025
Avoro Capital Advisors LLC
1.24M
2.78%
-100.00K
-7.48%
Jun 30, 2025
查看更多
持股ETF
更新时间: 11月2日 周日
更新时间: 11月2日 周日
机构名称
占比
Invesco Dorsey Wright SmallCap Momentum ETF
0.45%
First Trust Multi-Manager Small Cap Opportunities ETF
0.35%
iShares Russell 2000 Value ETF
0.03%
Avantis US Small Cap Equity ETF
0.02%
ProShares UltraPro Russell2000
0.01%
Schwab U.S. Small-Cap ETF
0.01%
Global X Russell 2000 ETF
0.01%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
查看更多
Invesco Dorsey Wright SmallCap Momentum ETF
占比0.45%
First Trust Multi-Manager Small Cap Opportunities ETF
占比0.35%
iShares Russell 2000 Value ETF
占比0.03%
Avantis US Small Cap Equity ETF
占比0.02%
ProShares UltraPro Russell2000
占比0.01%
Schwab U.S. Small-Cap ETF
占比0.01%
Global X Russell 2000 ETF
占比0.01%
ProShares Hedge Replication ETF
占比0.01%
iShares Russell 2000 ETF
占比0.01%
Proshares Ultra Russell 2000
占比0.01%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
